SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $280,503 | -9.0% | 2,314 | +3.4% | 0.00% | 0.0% |
| Q2 2023 | $308,325 | 0.0% | 2,237 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $308,325 | +6.2% | 2,237 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $290,388 | +19.5% | 2,241 | +1.5% | 0.00% | 0.0% |
| Q3 2022 | $243,000 | -29.2% | 2,208 | +9.2% | 0.00% | 0.0% |
| Q4 2020 | $343,000 | +15.5% | 2,022 | -4.9% | 0.00% | 0.0% |
| Q3 2020 | $297,000 | -12.6% | 2,126 | -0.1% | 0.00% | 0.0% |
| Q2 2020 | $340,000 | +25.0% | 2,128 | +0.9% | 0.00% | +100.0% |
| Q1 2020 | $272,000 | 0.0% | 2,109 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $272,000 | +72.2% | 2,109 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $158,000 | -50.6% | 2,109 | -0.2% | 0.00% | 0.0% |
| Q2 2019 | $320,000 | +27.5% | 2,113 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $251,000 | +14.6% | 2,113 | +5.0% | 0.00% | 0.0% |
| Q4 2018 | $219,000 | -32.2% | 2,013 | +0.6% | 0.00% | 0.0% |
| Q3 2018 | $323,000 | +22.3% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $264,000 | +107.9% | 2,000 | -13.0% | 0.00% | 0.0% |
| Q1 2018 | $127,000 | 0.0% | 2,300 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $127,000 | +41.1% | 2,300 | +15.0% | 0.00% | – |
| Q3 2017 | $90,000 | +52.5% | 2,000 | 0.0% | 0.00% | – |
| Q2 2017 | $59,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2017 | $59,000 | +9.3% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $54,000 | -56.5% | 2,000 | -1.9% | 0.00% | -100.0% |
| Q3 2016 | $124,000 | +226.3% | 2,038 | +1.9% | 0.00% | – |
| Q2 2016 | $38,000 | -2.6% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $39,000 | -49.4% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $77,000 | +20.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2015 | $64,000 | +6.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2015 | $60,000 | -34.8% | 2,000 | -71.4% | 0.00% | -100.0% |
| Q1 2015 | $92,000 | -8.9% | 7,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $101,000 | -17.2% | 7,000 | +20.7% | 0.00% | 0.0% |
| Q3 2014 | $122,000 | -29.1% | 5,800 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $172,000 | +23.7% | 5,800 | 0.0% | 0.00% | +100.0% |
| Q1 2014 | $139,000 | +17.8% | 5,800 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $118,000 | -52.2% | 5,800 | +10.8% | 0.00% | -66.7% |
| Q3 2013 | $247,000 | +30.0% | 5,235 | +4.7% | 0.00% | +50.0% |
| Q2 2013 | $190,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |